The biotech industry is at the forefront of groundbreaking innovations, yet securing funding has become increasingly difficult in today’s volatile environment. Market fluctuations, evolving investor expectations, and heightened complexities—including policy changes within the Department of Health and Human Services (HHS), shifts in the FDA, tariffs affecting global supply chains, and uncertainty surrounding government investment—have created significant hurdles for companies seeking financial backing. In this insightful panel discussion, our moderator—a biotech CEO—will lead an engaging conversation on the current fundraising landscape and what the future may hold. The panel will explore common pitfalls, challenges, and strategic approaches that can drive success despite these headwinds. Joining the discussion are industry experts, including a venture capitalist, a non-dilutive funding specialist, and a seasoned business development professional, each offering unique perspectives on navigating funding challenges in biotech. Together, they will examine emerging investment trends, practical strategies for securing capital, and ways companies can adapt to shifting market conditions. This session will provide valuable insights for entrepreneurs, investors, and industry professionals looking to better understand the biotech funding ecosystem and position themselves for success in an increasingly competitive space.